DMARD Adherence in Rheumatoid Arthritis Care
DMARD nonadherence rates in patients with RA range from 0% to 100%, with inconsistent measurement tools and few validated interventions.
A comprehensive review published in the British Journal of Clinical Pharmacology highlights considerable variability in how disease-modifying antirheumatic drug (DMARD) nonadherence is measured, reported, and understood in rheumatoid arthritis (RA).
The true prevalence of nonadherence to DMARDs in RA is unknown, and the factors that are associated with nonadherence have not been clearly defined.
Researchers aimed to generate insights that could shape future research and support a framework to reduce DMARD nonadherence in practice.
Author's summary: Inconsistent measurement tools complicate RA care.